Cargando…
Participating in innovative medicines initiative funded neurodegenerative disorder projects—An impact analysis conducted as part of the NEURONET project
The European Commission's Innovative Medicines Initiative (IMI) has funded many projects focusing on neurodegenerative disorders (ND) that aimed to improve the diagnosis, prevention, treatment and understanding of NDs. To facilitate collaboration across this project portfolio, the IMI funded th...
Autores principales: | Hawksworth, Claire, Salih, Fatima, Cresswell, Katharine, Steukers, Lennert, Diaz, Carlos, Killin, Lewis, Pradier, Laurent, Bradshaw, Angela, Dawoud, Dalia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10060789/ https://www.ncbi.nlm.nih.gov/pubmed/37006486 http://dx.doi.org/10.3389/fneur.2023.1140722 |
Ejemplares similares
-
The Innovative Medicines Initiative neurodegeneration portfolio: From individual projects to collaborative networks
por: O'Rourke, Diana, et al.
Publicado: (2022) -
SW Neuronet – neuroscience for psychiatrists update day
por: Churchhouse, Gabrielle, et al.
Publicado: (2021) -
Data sharing in neurodegenerative disease research: challenges and learnings from the innovative medicines initiative public-private partnership model
por: Bradshaw, Angela, et al.
Publicado: (2023) -
Deep neural networks: wasd neuronet models, algorithms, and applications
por: Zhang, Yunong, et al.
Publicado: (2019) -
The Drawbacks of Project Funding for Epistemic Innovation: Comparing Institutional Affordances and Constraints of Different Types of Research Funding
por: Franssen, Thomas, et al.
Publicado: (2018)